PD-083 Pemetrexed (P) plus carboplatin (Cb) as 1st treatment for patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC): Results of both a multi-center European and an MD Anderson Cancer Center (MDACC) phase II trials
- 31 July 2005
- journal article
- abstracts
- Published by Elsevier in Lung Cancer
- Vol. 49, S91-91
- https://doi.org/10.1016/s0169-5002(05)80416-7
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: